Refine Results
- 必威体育赛事投注
- Applications and Industries
- Content Type
- Analysis Platform
- Language
1 - 20 of 81 results
Applied Filters
Quick Start Protocol for SureSelect XT HS2 RNA Library Preparation and Target Enrichment using a post-capture pooling workflow.
Quick Start Protocol for SureSelect XT HS2 DNA Library Preparation and Target Enrichment using a pre-capture pooling workflow.
Quick Start Protocol for SureSelect XT HS2 DNA Library Preparation and Target Enrichment using a post-capture pooling workflow.
Protocol for SureSelect XT HS2 RNA Library Preparation and Target Enrichment featuring pre-capture pooling.
Protocol for SureSelect XT HS2 RNA Library Preparation and Target Enrichment for the Illumina platform.
Protocol for SureSelect XT HS2 mRNA Library Preparation with Poly-A Selection for NGS using the Illumina platform.
必威体育登录手机Protocol for SureSelect QXT Automated Target Enrichment for Illumina on the Agilent NGS Workstation Option B
SureSelect QXT Automated Target Enrichment for Illumina Multiplexed Sequencing Protocol (NGS Bravo Option A)
Protocol for SureSelect XT Automated Library Prep and Capture System for Illumina on the NGS Workstation
Protocol for Magnis NGS Prep System-automated preparation of SureSelect XT HS target-enriched NGS libraries for Illumina paired-end multiplexed sequencing.
Comparison of Manual and Automated NGS Library Preparation Using the Magnis Dx NGS Prep System with Cancer All-In-One Assay on FFPE Samples
SureSelect Target Enrichment System for Sequencing on Ion Proton Protocol
SureSelect QXT Target Enrichment for Illumina Multiplexed Sequencing Protocol
SureSelect XT Target Enrichment System for the Illumina Platform Protocol
必威体育登录手机Optimization of an Agilent NGS Automated Workflow for the Characterization of NSCLC DNA Samples in a Molecular Diagnostic and Anatomic Pathology Laboratory
必威体育登录手机Instructions for installing Agilent SureCall version 4.2.
This study aims to determine how precise targeting of all T cell receptor genes may assist diagnosis and surveillance of T cell malignancies.
"Many types of cancers are caused by either inherited or de novo genomic abnormalities such as single-nucleotide variants (SNVs), copy number variations (CNVs), and/or chromosomal translocations."
Describes the G5580A BenchCel Microplate Handler and earlier R- Series models.This guide covers installation, setup, operation, and maintenance.
Read application note to learn how the Glasgow Precision Oncology Laboratory (GPOL) evaluated the MagnisDx system for use in oncology testing with a specific focus on rapid turnaround time (TAT).